— Know what they know.
Not Investment Advice

INTC vs LRCX vs AMAT

161 measures in 16 categories, one definition each, computed from filings and market data.
INTC47.4
Intel Corp.
Technology · Semiconductors
$89.85 −5.79%$475.0B mkt cap
Score DNA
LRCX75.7
Lam Research Corporation
Technology · Semiconductors
$263.94 −4.87%$330.3B mkt cap
Score DNA
AMAT69.4
Applied Materials, Inc.
Technology · Semiconductors
$409.29 −4.82%$324.8B mkt cap
Score DNA

Price, rebased to 100 three years ago

INTC   LRCX   AMAT   · weekly adjusted closes
50100150200250300350400450500550600650Jan 24Apr 24Jul 24Oct 24Jan 25Apr 25Jul 25Oct 25Jan 26Apr 26Jul 26Oct 26LRCX 418AMAT 296INTC 254
● marks the highest or lowest value where that direction is plainly stronger (margins, returns, coverage, leverage); multiples and yields are left unmarked. Bars show each stock's percentile within its own industry. n/a: the measure does not apply to lenders and insurers.

Smart money

8 measures
MeasureINTCLRCXAMAT
Insider open-market buys, 180d 1 0 0
Insider $ bought, 180d $10.00M — —
Congress purchases, 180d 10 0 14
Last Congress purchase 2026-09-04 — 2026-08-06
13F net change in holders +990 +504 +572
ETFs adding shares, 30d 2,069 2,233 2,149
ETFs trimming, 30d 1,503 1,707 1,685
Net ETF funds, 30d +566 +526 +464

Valuation

16 measures
MeasureINTCLRCXAMAT
P/E (TTM) — 45.5x
49th
35.1x
24th
PEG (P/E ÷ 3-yr EPS CAGR) — 2.30
50th
2.36
56th
Price / sales 8.3x
51st
14.2x
75th
10.5x
57th
Price / book 5.4x
49th
26.5x
96th
12.7x
76th
Price / tangible book 10.1x
49th
45.2x
88th
20.0x
72nd
Price / free cash flow 167.8x
89th
67.5x
61st
57.8x
52nd
Price / operating cash flow 31.8x
41st
56.4x
69th
38.7x
50th
Enterprise value $495.8B
95th
$328.8B
93rd
$322.9B
92nd
EV / sales 8.7x
52nd
14.2x
74th
10.5x
60th
EV / EBITDA 135.0x
87th
37.8x
61st
28.0x
49th
EV / EBIT — 39.8x
55th
29.3x
32nd
EV / free cash flow 175.1x
94th
67.2x
63rd
57.4x
50th
Earnings yield -2.4%
16th
2.2%
67th
2.9%
84th
FCF yield 0.6%
36th
1.5%
56th
1.7%
63rd
Operating cash flow yield 3.1%
68th
1.8%
47th
2.6%
61st
Graham number (per share) — $35.80
54th
$91.37
88th

Profitability (TTM)

12 measures
MeasureINTCLRCXAMAT
Gross margin 38.9%
33rd
50.5%
57th
49.4%
52nd
EBITDA margin 6.4%
27th
37.5%
86th
37.4%
85th
Operating margin 0.1%
31st
35.3%
89th
30.5%
85th
EBIT margin -15.3%
12th
35.6%
86th
35.7%
88th
Net margin -19.8%
13th
31.3%
91st
30.1%
87th
NOPAT margin 0.1%
32nd
31.0%
88th
26.4%
83rd
FCF margin 5.0%
37th
21.1%
75th
18.2%
68th
Operating cash flow margin 26.2%
72nd
25.2%
71st
27.2%
76th
R&D / revenue 23.1%
67th
10.2%
24th
12.9%
35th
SG&A / revenue 7.9%
16th
4.9%
7th
5.4%
9th
Stock comp / revenue 4.2%
54th
1.7%
21st
2.2%
31st
Effective tax rate 21.0%
64th
12.1%
19th
13.6%
29th

Returns on capital

11 measures
MeasureINTCLRCXAMAT
ROE (on average equity) -12.2%
12th
65.1%
96th
41.1%
93rd
ROA -5.7%
15th
32.4%
97th
23.8%
91st
ROIC 0.1%
29th
65.5%
93rd
34.2%
87th
ROCE -5.2%
13th
47.0%
97th
33.2%
92nd
Return on tangible assets -4.4%
15th
36.8%
96th
28.3%
91st
Cash ROIC (OCF / invested capital) 13.8%
49th
53.2%
95th
35.4%
81st
Gross profitability (GP / assets) 11.0%
15th
49.8%
96th
35.0%
73rd
ROIC, 3-yr average -4.3%
16th
53.3%
96th
37.0%
89th
ROIC, 5-yr average 0.1%
17th
62.6%
87th
51.3%
86th
ROE, 5-yr average -3.0%
16th
57.1%
97th
41.7%
94th
Incremental ROIC -154.0%
7th
126.6%
89th
33.2%
63rd

Growth

17 measures
MeasureINTCLRCXAMAT
Revenue growth (TTM YoY) 7.5%
27th
26.0%
64th
7.8%
29th
Revenue growth (QoQ) 18.8%
71st
15.1%
56th
15.2%
60th
Revenue CAGR, 3 yr 1.8%
43rd
10.1%
66th
5.1%
56th
Revenue CAGR, 5 yr -6.0%
6th
9.7%
61st
7.4%
52nd
Gross profit CAGR, 3 yr 2.4%
47th
14.7%
70th
7.3%
59th
Operating income CAGR, 3 yr — 16.6%
75th
7.0%
62nd
Net income growth (TTM YoY) — 35.6%
51st
35.6%
54th
Net income CAGR, 3 yr — 17.2%
74th
12.9%
69th
EPS growth (TTM YoY) — 37.3%
49th
37.5%
51st
EPS CAGR, 3 yr — 19.7%
77th
14.8%
69th
EPS CAGR, 5 yr — 16.2%
68th
14.9%
59th
FCF growth (TTM YoY) — -14.4%
20th
-3.4%
33rd
FCF CAGR, 3 yr — 1.5%
49th
-7.0%
34th
Operating cash flow CAGR, 3 yr 15.3%
64th
4.2%
54th
1.6%
44th
Book value CAGR, 3 yr -10.7%
6th
17.4%
79th
21.4%
81st
Dividend CAGR, 3 yr 180.2%
100th
5.6%
70th
5.8%
74th
Sustainable growth rate — 53.7%
94th
34.4%
92nd

Margin history & stability

7 measures
MeasureINTCLRCXAMAT
Gross margin, 3-yr average 36.7%
28th
48.8%
57th
48.4%
54th
Operating margin, 3-yr average -7.8%
25th
32.0%
90th
29.9%
89th
Net margin, 3-yr average -18.9%
17th
28.7%
90th
27.2%
86th
FCF margin, 3-yr average -12.8%
11th
26.9%
89th
21.0%
72nd
Revenue stability (0-1) 0.58
50th
0.63
56th
0.97
96th
Earnings stability (0-1) 0.81
89th
0.59
72nd
0.75
83rd
Margin stability (0-1) 0.77
14th
0.95
71st
0.97
83rd

Liquidity (latest quarter)

7 measures
MeasureINTCLRCXAMAT
Cash & short-term investments $29.7B
97th
$5.6B
88th
$9.2B
93rd
Net cash (− = net debt) −$20.8B
1st
$1.5B
91st
$1.9B
93rd
Working capital $21.5B
96th
$9.7B
89th
$14.7B
93rd
Current ratio 1.60
7th
2.63
32nd
2.42
25th
Quick ratio 1.25
9th
1.91
33rd
1.79
27th
Cash ratio (cash + ST investments / current liabilities) 0.83
19th
0.94
25th
0.89
23rd
Defensive interval (days) 557 days
32nd
1,130 days
72nd
1,060 days
65th

Leverage & solvency (latest quarter)

13 measures
MeasureINTCLRCXAMAT
Total debt $50.5B
99th
$4.1B
80th
$7.3B
91st
Debt / equity 0.58
75th
0.33
64th
0.29
60th
Net debt / equity 0.24
80th
−0.12
60th
−0.07
64th
Debt / assets 25.0%
68th
17.5%
59th
16.9%
55th
Debt / capital 36.6%
75th
24.8%
64th
22.3%
60th
Debt / EBITDA 13.76
95th
0.47
37th
0.64
39th
Net debt / EBITDA 5.67
100th
−0.17
64th
−0.16
66th
Interest coverage (EBIT / interest) −7.6x
15th
66.5x
81st
39.7x
74th
Cash interest coverage 13.0x
43rd
47.1x
72nd
30.3x
67th
Debt payback (years of OCF) 3.4 yrs
76th
0.7 yrs
40th
0.9 yrs
43rd
Liabilities / assets 49.0%
77th
47.0%
69th
41.1%
63rd
IS credit model rating BB+ AA+ AA+
Implied credit spread (bps) 400
92nd
65
0th
65
0th

Efficiency

11 measures
MeasureINTCLRCXAMAT
Asset turnover 0.29
16th
1.04
97th
0.79
84th
Fixed asset turnover 0.54
3rd
7.86
79th
4.80
53rd
Inventory turnover 2.9
65th
2.7
51st
2.5
41st
Receivables turnover 17.8
100th
5.3
33rd
4.6
23rd
Days sales outstanding 20 days
0th
68 days
67th
80 days
77th
Days inventory outstanding 125 days
35th
136 days
49th
145 days
59th
Days payables outstanding 102 days
92nd
34 days
12th
49 days
48th
Cash conversion cycle (days) 44 days
5th
170 days
65th
176 days
68th
Capex / revenue 21.2%
91st
4.2%
41st
9.0%
74th
Capex / depreciation 0.98
57th
2.19
85th
5.30
99th
Operating expense ratio 29.2%
46th
14.4%
9th
16.6%
16th

Cash flow & earnings quality

7 measures
MeasureINTCLRCXAMAT
Operating cash flow / net income — 0.81
15th
0.91
25th
FCF / net income — 0.67
27th
0.61
17th
FCF / operating cash flow 19.0%
9th
83.5%
67th
67.0%
35th
Capex / operating cash flow 81.0%
91st
16.5%
33rd
33.0%
65th
Accruals ratio -13.3%
12th
6.3%
93rd
2.2%
85th
Sloan accruals ratio 0.4%
37th
5.7%
57th
6.1%
59th
Earnings quality score (0-1) — 0.75
15th
0.75
15th

Dividends & buybacks

9 measures
MeasureINTCLRCXAMAT
Dividend yield 0.0%
0th
0.4%
73rd
0.5%
75th
Dividend per share (TTM) $0.00
0th
$1.11
84th
$1.98
87th
Payout ratio (dividends / net income) — 17.5%
63rd
16.3%
62nd
Dividends / FCF 506.5%
100th
26.0%
70th
26.9%
72nd
Dividend growth (YoY) — 11.9%
70th
13.9%
74th
Buyback yield 0.1%
57th
1.2%
83rd
0.6%
72nd
Shareholder yield (dividends + buybacks) 3.1%
87th
1.6%
72nd
1.1%
64th
Share count change (YoY) 16.8%
90th
-1.2%
14th
-1.4%
11th
Buybacks, last 5 years $0
0th
$19.7B
96th
$19.0B
95th

Scores & forensic checks

15 measures
MeasureINTCLRCXAMAT
IS score 47
31st
76
81st
69
69th
IS profitability 20
28th
96
92nd
95
89th
IS growth 73
62nd
83
88th
66
45th
IS value 31
20th
40
71st
38
59th
IS momentum 69
38th
86
64th
79
49th
IS risk (safety) 100
12th
100
12th
100
12th
IS quality 49
27th
85
87th
83
79th
IS balance sheet 39
11th
92
73rd
92
76th
IS earnings quality 49
25th
52
31st
61
39th
IS cash flow 30
15th
62
60th
58
48th
Piotroski F-score (0-9) 7
65th
8
91st
6
43rd
Altman Z-score 4.5
16th
30.7
81st
18.3
65th
Beneish M-score −2.68
29th
−1.70
79th
−2.04
68th
Ohlson O-score −9.07
53rd
−10.54
29th
−10.71
25th
IS credit score 45
4th
93
91st
91
83rd

Per share

7 measures
MeasureINTCLRCXAMAT
EPS, diluted (TTM) −$2.21
4th
$5.76
81st
$11.58
95th
Book value per share $17.15
48th
$9.89
27th
$32.03
76th
Tangible book per share $15.70
65th
$8.43
37th
$27.00
81st
Revenue per share $11.17
41st
$18.42
63rd
$38.55
89th
FCF per share $0.55
37th
$3.88
79th
$7.03
89th
Operating cash flow per share $2.93
60th
$4.64
72nd
$10.49
91st
Cash per share $5.82
47th
$4.42
32nd
$11.54
79th

Size (TTM)

8 measures
MeasureINTCLRCXAMAT
Market cap $475.0B
95th
$330.3B
93rd
$324.8B
92nd
Revenue $57.0B
96th
$23.2B
91st
$30.8B
92nd
EBITDA $3.7B
83rd
$8.7B
91st
$11.5B
95th
Net income −$11.3B
0th
$7.3B
93rd
$9.3B
96th
Free cash flow $2.8B
84th
$4.9B
89th
$5.6B
93rd
Total assets $202.4B
99th
$23.5B
83rd
$43.5B
91st
Shareholders' equity $87.5B
96th
$12.5B
84th
$25.6B
91st
Employees 85,100
99th
23,300
83rd
36,500
92nd

Price performance

9 measures
MeasureINTCLRCXAMAT
1 day −5.8% −4.9% −4.8%
1 week −14.2% −17.2% −19.3%
1 month −17.4% −1.9% −1.9%
3 months −7.4% −14.0% −22.1%
6 months +31.2% −1.4% +3.1%
Year to date +128.2% +42.8% +52.4%
1 year +141.9% +82.6% +80.2%
3 years, cumulative +147.7% +320.6% +193.7%
5 years, cumulative +81.3% +403.4% +236.8%

Technicals

4 measures
MeasureINTCLRCXAMAT
RSI 14 31.4 30.3 29.2
From 52-week high −36.9% −39.8% −44.7%
From 52-week low +173.2% +95.1% +101.6%
Beta 2.23 1.85 1.59
InsiderStreet reports findings from filings and market data. A comparison is not a recommendation to buy or sell either stock.Every figure is computed in code · data as of 2026-10-17

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms